http://www.thiomatrix.com/img/flash%20files/flaintro.png
 

 

 


OR  AND 

 

 

 

FORMULATION DEVELOPMENT

 

NASAL DRUG DELIVERY SYSTEMS

 

Drug delivery through the nose offers the advantage of a comparatively rapid onset of action that is essential for the treatment of e.g. pain relief, erectile dysfunction or nausea. In comparison to oral drug delivery systems a higher bioavailability of peptide drugs in particular by utilizing the thiomer-technology can be achieved. ThioMatrix is well versed in the design and development of liquid, semisolid and solid nasal drug delivery systems. The development includes:

  • orientating permeation studies on nasal membranes

  • evaluations of the stability of the drug on the nasal mucosa towards membrane bound enzymes

  • orientating toxicity studies (cytotoxicity studies; ciliary beat frequency studies; histological examinations; etc.)

  • optimisation of the delivery system

  • storage stability studies

  • in vivo pharmacokinetic studies in various animal species

  • orientating studies in humans


Download a pdf (Nasal Drug Delivery)

Download a pdf (Non-invasive Peptide Drug Delivery)

 

 

 

 

Research Center Innsbruck:
Trientlgasse 65
6020 Innsbruck, Austria
Tel.: +43 512 890046-0
Fax.: +43 512 890046-15
e-mail: info@thiomatrix.com
Business Center St. Veit:
Unterer Platz 22
9300 St. Veit a.d. Glan, Austria
Tel: +43 650 7536270
Fax: +43 650 75362702
e-mail: info@thiomatrix.com

 

(c) All rights reserved | Site Map | Disclaimer | Imprint | Contact |